AZD1222 Covid-19 Vaccine and Serum Institute of India Ltd have/had a generic relationship

Planned distributor AZD1222 Covid-19 Vaccine
Planned distributor Serum Institute of India Ltd
Start Date 2020-06-00
Notes AstraZeneca partnered with the Serum Institute of India to supply doses to low-and-middle income countries. 400 million of these should be ready by the end of 2020.
Updated about 4 years ago

Source Links